GABAergic System in Action: Connection to Gastrointestinal Stress-related Disorders

Rosa Maria Serio, Michelangelo Auteri, Josipa Vlainić, Maja Jazvinšćak Jembrek

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Currently, treatment of stress-related gastrointestinal disorders, such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), is mainly symptomatic since there is no drug on the market that solves effectively diverse disease symptoms and comorbid states. Recently GABA receptors have been identified within gastrointestinal system and it has been recognized that among various GABAergic drugs some of them influence gastrointestinal stress-related diseases. Among them benzodiazepines have been investigated due to their diverse effects: neuroimmunomodulatory, relief of visceral pain and anxiolytic action.Conclusion: The present review brings findings on the expression of GABA receptors in the gastrointestinal tract and the role of GABA within it. We also present knowledge on the role of neurotransmitter GABA and various GABAergic ligands on diverse physiologic gastrointestinal functions with special emphasize to stress-related disorders. The rationale for therapeutic use and further identification of a potential GABAergic treatment of stress-related disorders has been critically discussed.
Original languageEnglish
Pages (from-to)4003-4011
Number of pages9
JournalCURRENT PHARMACEUTICAL DESIGN
Volume23
Publication statusPublished - 2017

Fingerprint

GABA Receptors
gamma-Aminobutyric Acid
Visceral Pain
Irritable Bowel Syndrome
Anti-Anxiety Agents
Therapeutic Uses
Benzodiazepines
Inflammatory Bowel Diseases
Pharmaceutical Preparations
Neurotransmitter Agents
Gastrointestinal Tract
Ligands
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Cite this

GABAergic System in Action: Connection to Gastrointestinal Stress-related Disorders. / Serio, Rosa Maria; Auteri, Michelangelo; Vlainić, Josipa; Jembrek, Maja Jazvinšćak.

In: CURRENT PHARMACEUTICAL DESIGN, Vol. 23, 2017, p. 4003-4011.

Research output: Contribution to journalArticle

@article{ee48d39235784a8392b21098100dedee,
title = "GABAergic System in Action: Connection to Gastrointestinal Stress-related Disorders",
abstract = "Background: Currently, treatment of stress-related gastrointestinal disorders, such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), is mainly symptomatic since there is no drug on the market that solves effectively diverse disease symptoms and comorbid states. Recently GABA receptors have been identified within gastrointestinal system and it has been recognized that among various GABAergic drugs some of them influence gastrointestinal stress-related diseases. Among them benzodiazepines have been investigated due to their diverse effects: neuroimmunomodulatory, relief of visceral pain and anxiolytic action.Conclusion: The present review brings findings on the expression of GABA receptors in the gastrointestinal tract and the role of GABA within it. We also present knowledge on the role of neurotransmitter GABA and various GABAergic ligands on diverse physiologic gastrointestinal functions with special emphasize to stress-related disorders. The rationale for therapeutic use and further identification of a potential GABAergic treatment of stress-related disorders has been critically discussed.",
keywords = "GABAergic system, Stress, benzodiazepines, gastrointestinal system, stress-related disorders, therapy",
author = "Serio, {Rosa Maria} and Michelangelo Auteri and Josipa Vlainić and Jembrek, {Maja Jazvinšćak}",
year = "2017",
language = "English",
volume = "23",
pages = "4003--4011",
journal = "CURRENT PHARMACEUTICAL DESIGN",
issn = "1381-6128",

}

TY - JOUR

T1 - GABAergic System in Action: Connection to Gastrointestinal Stress-related Disorders

AU - Serio, Rosa Maria

AU - Auteri, Michelangelo

AU - Vlainić, Josipa

AU - Jembrek, Maja Jazvinšćak

PY - 2017

Y1 - 2017

N2 - Background: Currently, treatment of stress-related gastrointestinal disorders, such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), is mainly symptomatic since there is no drug on the market that solves effectively diverse disease symptoms and comorbid states. Recently GABA receptors have been identified within gastrointestinal system and it has been recognized that among various GABAergic drugs some of them influence gastrointestinal stress-related diseases. Among them benzodiazepines have been investigated due to their diverse effects: neuroimmunomodulatory, relief of visceral pain and anxiolytic action.Conclusion: The present review brings findings on the expression of GABA receptors in the gastrointestinal tract and the role of GABA within it. We also present knowledge on the role of neurotransmitter GABA and various GABAergic ligands on diverse physiologic gastrointestinal functions with special emphasize to stress-related disorders. The rationale for therapeutic use and further identification of a potential GABAergic treatment of stress-related disorders has been critically discussed.

AB - Background: Currently, treatment of stress-related gastrointestinal disorders, such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), is mainly symptomatic since there is no drug on the market that solves effectively diverse disease symptoms and comorbid states. Recently GABA receptors have been identified within gastrointestinal system and it has been recognized that among various GABAergic drugs some of them influence gastrointestinal stress-related diseases. Among them benzodiazepines have been investigated due to their diverse effects: neuroimmunomodulatory, relief of visceral pain and anxiolytic action.Conclusion: The present review brings findings on the expression of GABA receptors in the gastrointestinal tract and the role of GABA within it. We also present knowledge on the role of neurotransmitter GABA and various GABAergic ligands on diverse physiologic gastrointestinal functions with special emphasize to stress-related disorders. The rationale for therapeutic use and further identification of a potential GABAergic treatment of stress-related disorders has been critically discussed.

KW - GABAergic system

KW - Stress

KW - benzodiazepines

KW - gastrointestinal system

KW - stress-related disorders

KW - therapy

UR - http://hdl.handle.net/10447/249848

M3 - Article

VL - 23

SP - 4003

EP - 4011

JO - CURRENT PHARMACEUTICAL DESIGN

JF - CURRENT PHARMACEUTICAL DESIGN

SN - 1381-6128

ER -